 | • レポートコード：GIR-22F2793 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Corticosteroids API Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界のコルチコステロイドAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 コルチコステロイドAPI市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・プレドニゾン系、デキサメタゾン系、ベタメタゾン系、トリアムシノロン、メチルプレドニゾロン、スピロノラクトン、その他 アプリケーション別セグメントは次のように区分されます。 ・喘息、関節炎、イウプス、アレルギー、その他 世界のコルチコステロイドAPI市場の主要な市場プレーヤーは以下のとおりです。 ・Pfizer Inc、Sanofi Active Ingredient Solutions、TEVA、Hovione、Farmabios、Steroid SpA、Avik Pharmaceutical、Anuh Pharma、Symbiotec、Wellona Pharma、Tianjin Tianyao Pharmaceutical、Zhejiang Xianju Pharmaceutical、Henan Lihua Pharmaceutical、Shanghai New Hualian Pharmaceutical、Zhejiang Hengdian Apeloa、Shandong Sito Bio-tech 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、コルチコステロイドAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なコルチコステロイドAPIメーカーの企業概要、2019年～2022年までのコルチコステロイドAPIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なコルチコステロイドAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別コルチコステロイドAPIの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのコルチコステロイドAPIのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのコルチコステロイドAPI市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびコルチコステロイドAPIの産業チェーンを掲載しています。 ・第13、14、15章では、コルチコステロイドAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - コルチコステロイドAPIの概要 - タイプ別分析（2017年vs2021年vs2028年）：プレドニゾン系、デキサメタゾン系、ベタメタゾン系、トリアムシノロン、メチルプレドニゾロン、スピロノラクトン、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：喘息、関節炎、イウプス、アレルギー、その他 - 世界のコルチコステロイドAPI市場規模・予測 - 世界のコルチコステロイドAPI生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer Inc、Sanofi Active Ingredient Solutions、TEVA、Hovione、Farmabios、Steroid SpA、Avik Pharmaceutical、Anuh Pharma、Symbiotec、Wellona Pharma、Tianjin Tianyao Pharmaceutical、Zhejiang Xianju Pharmaceutical、Henan Lihua Pharmaceutical、Shanghai New Hualian Pharmaceutical、Zhejiang Hengdian Apeloa、Shandong Sito Bio-tech ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：プレドニゾン系、デキサメタゾン系、ベタメタゾン系、トリアムシノロン、メチルプレドニゾロン、スピロノラクトン、その他 ・アプリケーション別分析2017年-2028年：喘息、関節炎、イウプス、アレルギー、その他 ・コルチコステロイドAPIの北米市場分析 - コルチコステロイドAPIの北米市場：タイプ別市場規模2017年-2028年 - コルチコステロイドAPIの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・コルチコステロイドAPIのヨーロッパ市場分析 - ：コルチコステロイドAPIのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：コルチコステロイドAPIのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・コルチコステロイドAPIのアジア太平洋市場分析 - コルチコステロイドAPIのアジア太平洋市場：タイプ別市場規模2017年-2028年 - コルチコステロイドAPIのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・コルチコステロイドAPIの南米市場分析 - コルチコステロイドAPIの南米市場：タイプ別市場規模2017年-2028年 - コルチコステロイドAPIの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・コルチコステロイドAPIの中東・アフリカ市場分析 - コルチコステロイドAPIの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - コルチコステロイドAPIの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Corticosteroids API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Corticosteroids API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Asthma accounting for % of the Corticosteroids API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prednisone Series segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Corticosteroids API include Pfizer Inc, Sanofi Active Ingredient Solutions, TEVA, Hovione, and Farmabios, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Corticosteroids API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prednisone Series
Dexamethasone Series
Betamethasone Series
Triamcinolone
Methylprednisolone
Spironolactone
Other
Market segment by Application can be divided into
Asthma
Arthritis
Iupus
Allergies
Other
The key market players for global Corticosteroids API market are listed below:
Pfizer Inc
Sanofi Active Ingredient Solutions
TEVA
Hovione
Farmabios
Steroid SpA
Avik Pharmaceutical
Anuh Pharma
Symbiotec
Wellona Pharma
Tianjin Tianyao Pharmaceutical
Zhejiang Xianju Pharmaceutical
Henan Lihua Pharmaceutical
Shanghai New Hualian Pharmaceutical
Zhejiang Hengdian Apeloa
Shandong Sito Bio-tech
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Corticosteroids API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Corticosteroids API, with price, sales, revenue and global market share of Corticosteroids API from 2019 to 2022.
Chapter 3, the Corticosteroids API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Corticosteroids API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Corticosteroids API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Corticosteroids API.
Chapter 13, 14, and 15, to describe Corticosteroids API sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Corticosteroids API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Corticosteroids API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Prednisone Series
1.2.3 Dexamethasone Series
1.2.4 Betamethasone Series
1.2.5 Triamcinolone
1.2.6 Methylprednisolone
1.2.7 Spironolactone
1.2.8 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Corticosteroids API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 Arthritis
1.3.4 Iupus
1.3.5 Allergies
1.3.6 Other
1.4 Global Corticosteroids API Market Size & Forecast
1.4.1 Global Corticosteroids API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Corticosteroids API Sales in Volume (2017-2028)
1.4.3 Global Corticosteroids API Price (2017-2028)
1.5 Global Corticosteroids API Production Capacity Analysis
1.5.1 Global Corticosteroids API Total Production Capacity (2017-2028)
1.5.2 Global Corticosteroids API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Corticosteroids API Market Drivers
1.6.2 Corticosteroids API Market Restraints
1.6.3 Corticosteroids API Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Corticosteroids API Product and Services
2.1.4 Pfizer Inc Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi Active Ingredient Solutions
2.2.1 Sanofi Active Ingredient Solutions Details
2.2.2 Sanofi Active Ingredient Solutions Major Business
2.2.3 Sanofi Active Ingredient Solutions Corticosteroids API Product and Services
2.2.4 Sanofi Active Ingredient Solutions Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 TEVA
2.3.1 TEVA Details
2.3.2 TEVA Major Business
2.3.3 TEVA Corticosteroids API Product and Services
2.3.4 TEVA Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hovione
2.4.1 Hovione Details
2.4.2 Hovione Major Business
2.4.3 Hovione Corticosteroids API Product and Services
2.4.4 Hovione Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Farmabios
2.5.1 Farmabios Details
2.5.2 Farmabios Major Business
2.5.3 Farmabios Corticosteroids API Product and Services
2.5.4 Farmabios Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Steroid SpA
2.6.1 Steroid SpA Details
2.6.2 Steroid SpA Major Business
2.6.3 Steroid SpA Corticosteroids API Product and Services
2.6.4 Steroid SpA Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Avik Pharmaceutical
2.7.1 Avik Pharmaceutical Details
2.7.2 Avik Pharmaceutical Major Business
2.7.3 Avik Pharmaceutical Corticosteroids API Product and Services
2.7.4 Avik Pharmaceutical Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Anuh Pharma
2.8.1 Anuh Pharma Details
2.8.2 Anuh Pharma Major Business
2.8.3 Anuh Pharma Corticosteroids API Product and Services
2.8.4 Anuh Pharma Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Symbiotec
2.9.1 Symbiotec Details
2.9.2 Symbiotec Major Business
2.9.3 Symbiotec Corticosteroids API Product and Services
2.9.4 Symbiotec Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Wellona Pharma
2.10.1 Wellona Pharma Details
2.10.2 Wellona Pharma Major Business
2.10.3 Wellona Pharma Corticosteroids API Product and Services
2.10.4 Wellona Pharma Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Tianjin Tianyao Pharmaceutical
2.11.1 Tianjin Tianyao Pharmaceutical Details
2.11.2 Tianjin Tianyao Pharmaceutical Major Business
2.11.3 Tianjin Tianyao Pharmaceutical Corticosteroids API Product and Services
2.11.4 Tianjin Tianyao Pharmaceutical Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhejiang Xianju Pharmaceutical
2.12.1 Zhejiang Xianju Pharmaceutical Details
2.12.2 Zhejiang Xianju Pharmaceutical Major Business
2.12.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Product and Services
2.12.4 Zhejiang Xianju Pharmaceutical Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Henan Lihua Pharmaceutical
2.13.1 Henan Lihua Pharmaceutical Details
2.13.2 Henan Lihua Pharmaceutical Major Business
2.13.3 Henan Lihua Pharmaceutical Corticosteroids API Product and Services
2.13.4 Henan Lihua Pharmaceutical Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Shanghai New Hualian Pharmaceutical
2.14.1 Shanghai New Hualian Pharmaceutical Details
2.14.2 Shanghai New Hualian Pharmaceutical Major Business
2.14.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Product and Services
2.14.4 Shanghai New Hualian Pharmaceutical Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Zhejiang Hengdian Apeloa
2.15.1 Zhejiang Hengdian Apeloa Details
2.15.2 Zhejiang Hengdian Apeloa Major Business
2.15.3 Zhejiang Hengdian Apeloa Corticosteroids API Product and Services
2.15.4 Zhejiang Hengdian Apeloa Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Shandong Sito Bio-tech
2.16.1 Shandong Sito Bio-tech Details
2.16.2 Shandong Sito Bio-tech Major Business
2.16.3 Shandong Sito Bio-tech Corticosteroids API Product and Services
2.16.4 Shandong Sito Bio-tech Corticosteroids API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Corticosteroids API Breakdown Data by Manufacturer
3.1 Global Corticosteroids API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Corticosteroids API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Corticosteroids API
3.4 Market Concentration Rate
3.4.1 Top 3 Corticosteroids API Manufacturer Market Share in 2021
3.4.2 Top 6 Corticosteroids API Manufacturer Market Share in 2021
3.5 Global Corticosteroids API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Corticosteroids API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Corticosteroids API Market Size by Region
4.1.1 Global Corticosteroids API Sales in Volume by Region (2017-2028)
4.1.2 Global Corticosteroids API Revenue by Region (2017-2028)
4.2 North America Corticosteroids API Revenue (2017-2028)
4.3 Europe Corticosteroids API Revenue (2017-2028)
4.4 Asia-Pacific Corticosteroids API Revenue (2017-2028)
4.5 South America Corticosteroids API Revenue (2017-2028)
4.6 Middle East and Africa Corticosteroids API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Corticosteroids API Sales in Volume by Type (2017-2028)
5.2 Global Corticosteroids API Revenue by Type (2017-2028)
5.3 Global Corticosteroids API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Corticosteroids API Sales in Volume by Application (2017-2028)
6.2 Global Corticosteroids API Revenue by Application (2017-2028)
6.3 Global Corticosteroids API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Corticosteroids API Sales by Type (2017-2028)
7.2 North America Corticosteroids API Sales by Application (2017-2028)
7.3 North America Corticosteroids API Market Size by Country
7.3.1 North America Corticosteroids API Sales in Volume by Country (2017-2028)
7.3.2 North America Corticosteroids API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Corticosteroids API Sales by Type (2017-2028)
8.2 Europe Corticosteroids API Sales by Application (2017-2028)
8.3 Europe Corticosteroids API Market Size by Country
8.3.1 Europe Corticosteroids API Sales in Volume by Country (2017-2028)
8.3.2 Europe Corticosteroids API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Corticosteroids API Sales by Type (2017-2028)
9.2 Asia-Pacific Corticosteroids API Sales by Application (2017-2028)
9.3 Asia-Pacific Corticosteroids API Market Size by Region
9.3.1 Asia-Pacific Corticosteroids API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Corticosteroids API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Corticosteroids API Sales by Type (2017-2028)
10.2 South America Corticosteroids API Sales by Application (2017-2028)
10.3 South America Corticosteroids API Market Size by Country
10.3.1 South America Corticosteroids API Sales in Volume by Country (2017-2028)
10.3.2 South America Corticosteroids API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Corticosteroids API Sales by Type (2017-2028)
11.2 Middle East & Africa Corticosteroids API Sales by Application (2017-2028)
11.3 Middle East & Africa Corticosteroids API Market Size by Country
11.3.1 Middle East & Africa Corticosteroids API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Corticosteroids API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Corticosteroids API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Corticosteroids API
12.3 Corticosteroids API Production Process
12.4 Corticosteroids API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Corticosteroids API Typical Distributors
13.3 Corticosteroids API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer